Schonfeld Strategic Advisors LLC Regencell Bioscience Holdings LTD Transaction History
Schonfeld Strategic Advisors LLC
- $15 Billion
- Q1 2025
Shares
2 transactions
Others Institutions Holding RGC
# of Institutions
10Shares Held
417KCall Options Held
0Put Options Held
0-
Geode Capital Management, LLC Boston, MA391KShares$5.26 Million0.0% of portfolio
-
Y Intercept (Hong Kong) LTD13KShares$175,2840.01% of portfolio
-
Greenfield Savings Bank11KShares$147,8400.09% of portfolio
-
Royal Bank Of Canada Toronto, A6948Shares$12,7410.0% of portfolio
-
Tower Research Capital LLC (Trc) New York, NY698Shares$9,3810.0% of portfolio
About Regencell Bioscience Holdings Ltd
- Ticker RGC
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 13,012,900
- Market Cap $175M
- Description
- Regencell Bioscience Holdings Limited operates a Traditional Chinese medicine (TCM) bioscience company. It focuses on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, primarily attention deficit hyperactivity disorder and autism spectrum disorder. The company was incorporated...